NIH Announces Recovery Act Limited Competition (RC4)

NIH Director’s Opportunity for Research in Five Thematic Areas:

  • Applying Genomics and Other High Throughput Technologies
  • Translating Basic Science Discoveries into New and Better Treatments
  • Using Science to Enable Health Care Reform
  • Focusing on Global Health
  • Reinvigorating the Biomedical Research Community

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-005.html

Due date: 03/15/10

Up to $80 million of ARRA funds will be obligated by September 20, 2010 for this FOA.

Budgets must be greater than $500,000 total costs per year for three years.

 

Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease, Eradication Methods for Methicillin Resistant Staphylococcus aureus and Dementia Detection and Management Strategies
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-008.html

Due date: 02/26/10

The NIH intends to commit $5,000,000 in each of the three targeted areas.

Total costs are limited to $1,250,000 over three years.

Methodology Development in Comparative Effectiveness Research
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-009.html

Due date: 02/26/10

The NIH intends to commit $10,000,000 for use under this FOA.

Total costs are limited to $1,500,000 over three years.
Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research: Pilot Research
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-002.html

Due date: 03/19/10

The NIH intends to commit $5,000,000 for use under this FOA.

Total costs are limited to $1,250,000 over three years.
Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research: Clinical Trials
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-001.html

Due date: 04/07/10

The NIH and AHRQ intend to commit $15,000,000 for use under this FOA.

Total costs are limited to $7,500,000 over three years.